Kilitch Drugs

{
  "main_header": {
    "sid": 189669,
    "name": "Kilitch Drugs",
    "stock_name": "Kilitch Drugs",
    "full_name": "Kilitch Drugs (India) Ltd",
    "name_url": "stocks-analysis/kilitch-drugs",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 1,
    "country_id": 34,
    "currency": "INR",
    "cmp": "225.00",
    "chg": 7.7,
    "chgp": "3.54%",
    "dir": 1,
    "prev_price": "217.30",
    "mcapval": "772.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 524500,
    "symbol": "KILITCH",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "sector_id": 65,
    "indexname": "India SENSEX",
    "isin": "INE729D01010",
    "curr_date": "Sep 25, 12:33 PM",
    "curr_time": "12:36 PM",
    "last_traded_at": "Sep 25, 12:33 PM IST",
    "bse_nse_vol": "21.74 k",
    "exc_status": "Active",
    "traded_date": "Sep 25, 2026",
    "traded_date_str": "2026 09 25",
    "score": "",
    "scoreText": "",
    "Live": 1,
    "market_time": 1,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/kilitch-drugs-189669-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "Broad-Based Technical Strength Lifts Kilitch Drugs (India) Ltd to 52-Week High of Rs 233.5",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/kilitch-drugs-india-ltd-hits-new-52-week-high-at-rs2335-4203218",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/KilitchDrugsInd_priceRelatedfactors_4203218.png",
        "date": "2026-09-24 09:40:09",
        "description": "With a decisive surge to Rs 233.5 on 24 Jun 2026, Kilitch Drugs (India) Ltd has reached a fresh 52-week high, marking a 92.7% rally from its low of Rs 121.1 over the past year. This milestone comes amid a backdrop of broad technical alignment and sustained price momentum, even as the broader Sensex trades near its own 52-week lows."
      },
      {
        "title": "Kilitch Drugs (India) Ltd Locks at Upper Circuit With 5% Gain — Buyers Queue, Sellers Absent",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/kilitch-drugs-india-ltd-hits-upper-circuit-surges-5-on-strong-buying-momentum-4202119",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/KilitchDrugsInd_stocks_hitting_upper_circuit_4202119.png",
        "date": "2026-09-23 10:00:08",
        "description": "At Rs 221.62, the buying was done — not because demand dried up, but because the exchange wouldn't let the stock go any higher. Kilitch Drugs (India) Ltd locked at its upper circuit of 5% on 23 Sep 2026, with buyers queuing and no sellers willing to part with shares."
      },
      {
        "title": "Broad-Based Technical Strength Lifts Kilitch Drugs (India) Ltd to 52-Week High of Rs 223.85",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/kilitch-drugs-india-ltd-hits-new-52-week-high-at-rs22385-4201998",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/KilitchDrugsInd_priceRelatedfactors_4201998.png",
        "date": "2026-09-23 09:46:05",
        "description": "Kilitch Drugs (India) Ltd has surged to a new 52-week high of Rs 223.85 on 23 Sep 2026, marking a significant milestone after a sustained rally that has delivered over 27% returns in the past year. This advance comes amid a backdrop of strong technical momentum and a market environment where the Sensex trades cautiously below key moving averages."
      },
      {
        "title": "Kilitch Drugs Upgraded to Hold as Technicals Improve Despite Mixed Financials",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/kilitch-drugs-upgraded-to-hold-as-technicals-improve-despite-mixed-financials-4201685",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/KilitchDrugsInd_mojoScore_4201685.png",
        "date": "2026-09-23 08:01:46",
        "description": "Kilitch Drugs (India) Ltd has seen its investment rating upgraded from Sell to Hold, reflecting notable improvements in technical indicators and a reassessment of valuation metrics despite recent financial headwinds. This shift comes amid a bullish technical trend, an expensive yet justified valuation, and a stable financial outlook, positioning the micro-cap pharmaceutical firm for cautious investor interest."
      },
      {
        "title": "Kilitch Drugs (India) Ltd Technical Momentum Shifts to Bullish Amid Strong Price Gains",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/kilitch-drugs-india-ltd-technical-momentum-shifts-to-bullish-amid-strong-price-gains-4201598",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/KilitchDrugsInd_technicaldot_4201598.png",
        "date": "2026-09-23 08:00:35",
        "description": "Kilitch Drugs (India) Ltd has demonstrated a notable shift in price momentum, with technical indicators signalling a transition from mildly bullish to bullish territory. The stock’s recent 5.00% gain and upgrades across key metrics suggest renewed investor interest amid a challenging pharmaceutical sector backdrop."
      },
      {
        "title": "Kilitch Drugs Valuation Shifts Signal Changing Market Perception",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/kilitch-drugs-valuation-shifts-signal-changing-market-perception-4201566",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/KilitchDrugsInd_valuationdot_4201566.png",
        "date": "2026-09-23 08:00:10",
        "description": "Kilitch Drugs (India) Ltd has witnessed a notable shift in its valuation parameters, moving from a fair to an expensive rating, reflecting evolving investor sentiment amid robust price gains and improving financial metrics. This article analyses the recent changes in key valuation ratios, compares them with industry peers, and assesses the implications for investors considering this micro-cap pharmaceutical player."
      },
      {
        "title": "Kilitch Drugs Locks at Upper Circuit With 5.0% Gain — Buyers Queue, Sellers Absent",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/kilitch-drugs-india-ltd-surges-to-upper-circuit-amid-robust-buying-pressure-4200969",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/KilitchDrugsInd_stocks_hitting_upper_circuit_4200969.png",
        "date": "2026-09-22 10:00:08",
        "description": "At Rs 211.07, the buying was done — not because demand dried up, but because the exchange wouldn't let the stock go any higher. Kilitch Drugs (India) Ltd locked at its upper circuit of 5.0% on 22 Sep 2026, with buyers queuing and no sellers willing to part with shares."
      },
      {
        "title": "Kilitch Drugs (India) Ltd Locks at Upper Circuit With 5% Gain — Buyers Queue, Sellers Absent",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/kilitch-drugs-india-ltd-hits-upper-circuit-amid-strong-buying-pressure-4200021",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/KilitchDrugsInd_stocks_hitting_upper_circuit_4200021.png",
        "date": "2026-09-21 13:00:06",
        "description": "At Rs 201.02, the buying was done — not because demand dried up, but because the exchange wouldn't let the stock go any higher. Kilitch Drugs (India) Ltd locked at its upper circuit of 5% on 21 Sep 2026, with buyers queuing and no sellers willing to part with shares."
      },
      {
        "title": "Kilitch Drugs (India) Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/kilitch-drugs-india-ltd-is-rated-sell-4199625",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/KilitchDrugsInd_mojoScore_4199625.png",
        "date": "2026-09-21 10:11:31",
        "description": "Kilitch Drugs (India) Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 25 August 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 21 September 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook."
      }
    ],
    "total": 380,
    "sid": "189669",
    "stock_news_url": "https://www.marketsmojo.com/news/kilitch-drugs-india-189669"
  },
  "announcements": [
    {
      "caption": "Shareholder Meeting / Postal Ballot-Scrutinizers Report",
      "datetime": "27-Aug-2026",
      "details": "We are submitting herewith the scrutinizers report for the voting process of 34th Annual General Meeting of Kilitch Drugs India Limited",
      "source": "BSE"
    },
    {
      "caption": "Shareholder Meeting / Postal Ballot-Outcome of AGM",
      "datetime": "27-Aug-2026",
      "details": "We are submitting herewith the proceeding of 34th Annual General Meeting",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
      "datetime": "18-Aug-2026",
      "details": "We are submitting herewith the publication of extract of the financial results for the quarter ended 30th June 2026",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Kilitch Drugs (India) Ltd has declared <strong>5%</strong> dividend, ex-date: 20 Sep 19",
          "dt": "2019-09-20",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "",
      "data": [
        {
          "txt": "Kilitch Drugs (India) Ltd has announced <strong>1:1</strong> bonus issue, ex-date: 24 Mar 26",
          "dt": "2026-03-24",
          "middle_text": "Bonus Alert"
        }
      ]
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "",
      "data": [
        {
          "txt": "Kilitch Drugs (India) Ltd has announced <strong>2:23</strong> rights issue, ex-date: 15 Jul 25",
          "dt": "2025-07-15",
          "middle_text": "Rights Issue"
        }
      ]
    }
  ]
}

News and Views

Broad-Based Technical Strength Lifts Kilitch Drugs (India) Ltd to 52-Week High of Rs 233.5

2026-09-24 09:40:09

With a decisive surge to Rs 233.5 on 24 Jun 2026, Kilitch Drugs (India) Ltd has reached a fresh 52-week high, marking a 92.7% rally from its low of Rs 121.1 over the past year. This milestone comes amid a backdrop of broad technical alignment and sustained price momentum, even as the broader Sensex trades near its own 52-week lows.

Read full news article

Kilitch Drugs (India) Ltd Locks at Upper Circuit With 5% Gain — Buyers Queue, Sellers Absent

2026-09-23 10:00:08

At Rs 221.62, the buying was done — not because demand dried up, but because the exchange wouldn't let the stock go any higher. Kilitch Drugs (India) Ltd locked at its upper circuit of 5% on 23 Sep 2026, with buyers queuing and no sellers willing to part with shares.

Read full news article

Broad-Based Technical Strength Lifts Kilitch Drugs (India) Ltd to 52-Week High of Rs 223.85

2026-09-23 09:46:05

Kilitch Drugs (India) Ltd has surged to a new 52-week high of Rs 223.85 on 23 Sep 2026, marking a significant milestone after a sustained rally that has delivered over 27% returns in the past year. This advance comes amid a backdrop of strong technical momentum and a market environment where the Sensex trades cautiously below key moving averages.

Read full news article

Kilitch Drugs Upgraded to Hold as Technicals Improve Despite Mixed Financials

2026-09-23 08:01:46

Kilitch Drugs (India) Ltd has seen its investment rating upgraded from Sell to Hold, reflecting notable improvements in technical indicators and a reassessment of valuation metrics despite recent financial headwinds. This shift comes amid a bullish technical trend, an expensive yet justified valuation, and a stable financial outlook, positioning the micro-cap pharmaceutical firm for cautious investor interest.

Read full news article

Kilitch Drugs (India) Ltd Technical Momentum Shifts to Bullish Amid Strong Price Gains

2026-09-23 08:00:35

Kilitch Drugs (India) Ltd has demonstrated a notable shift in price momentum, with technical indicators signalling a transition from mildly bullish to bullish territory. The stock’s recent 5.00% gain and upgrades across key metrics suggest renewed investor interest amid a challenging pharmaceutical sector backdrop.

Read full news article

Kilitch Drugs Valuation Shifts Signal Changing Market Perception

2026-09-23 08:00:10

Kilitch Drugs (India) Ltd has witnessed a notable shift in its valuation parameters, moving from a fair to an expensive rating, reflecting evolving investor sentiment amid robust price gains and improving financial metrics. This article analyses the recent changes in key valuation ratios, compares them with industry peers, and assesses the implications for investors considering this micro-cap pharmaceutical player.

Read full news article

Kilitch Drugs Locks at Upper Circuit With 5.0% Gain — Buyers Queue, Sellers Absent

2026-09-22 10:00:08

At Rs 211.07, the buying was done — not because demand dried up, but because the exchange wouldn't let the stock go any higher. Kilitch Drugs (India) Ltd locked at its upper circuit of 5.0% on 22 Sep 2026, with buyers queuing and no sellers willing to part with shares.

Read full news article

Kilitch Drugs (India) Ltd Locks at Upper Circuit With 5% Gain — Buyers Queue, Sellers Absent

2026-09-21 13:00:06

At Rs 201.02, the buying was done — not because demand dried up, but because the exchange wouldn't let the stock go any higher. Kilitch Drugs (India) Ltd locked at its upper circuit of 5% on 21 Sep 2026, with buyers queuing and no sellers willing to part with shares.

Read full news article

Kilitch Drugs (India) Ltd is Rated Sell

2026-09-21 10:11:31

Kilitch Drugs (India) Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 25 August 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 21 September 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.

Read full news article

View All News